![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Bone Changes With TDF-containing and Non-TDF-containing
(maraviroc) Prep in U.S. Men and Women
|
|
|
Reported by Jules Levin
CROI 2017 Feb 14-16 Seattle, WA
Todd T Brown1, Tim Wilkin2, Kenneth H Mayer3, Raphael J Landovitz4, Ying Q Chen5, Jing Wang6
Alicia Young6, Mark A Marzinke1, WairimuChege7, Marybeth McCauley8, Roy M Gulick2
1JohnsHopkinsUniversity,Baltimore, MD,2 Weill Cornell Medicine, New York, NY,3 Fenway Health, Boston, MA,4 UCLA Center for Clinical AIDS Research & Education, LosAngeles,CA,5 Fred Hutchinson Cancer Research Center, Seattle,WA,6 Statistical Center for HIV/AIDS Research and Prevention, Seattle,WA,7 National Institute of Allergy and Infectious Diseases, Bethesda, MD, 8FHI360, Washington, DC
![0310171](../images/031017/031017-6/0310171.gif)
![0310172](../images/031017/031017-6/0310172.gif)
![0310173](../images/031017/031017-6/0310173.gif)
![0310174](../images/031017/031017-6/0310174.gif)
![0310175](../images/031017/031017-6/0310175.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|